André Fe is a scholar working on Epidemiology, Health and Infectious Diseases.
According to data from OpenAlex, André Fe has authored 14 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 5 papers in Health and 3 papers in Infectious Diseases. Recurrent topics in André Fe's work include Vaccine Coverage and Hesitancy (5 papers), Hepatitis B Virus Studies (4 papers) and Viral gastroenteritis research and epidemiology (2 papers). André Fe is often cited by papers focused on Vaccine Coverage and Hesitancy (5 papers), Hepatitis B Virus Studies (4 papers) and Viral gastroenteritis research and epidemiology (2 papers). André Fe collaborates with scholars based in Belgium, Finland and South Korea. André Fe's co-authors include Somsak Lolekha, Schmitt Hj, Mathuram Santosham, BW Lee, Robert Booy, H.L. Bock, TJ John, Heikki Peltola, John D. Clemens and Assad Safary and has published in prestigious journals such as Bulletin of the World Health Organization, PubMed and Munich Personal RePEc Archive (Ludwig Maximilian University of Munich).
In The Last Decade
André Fe
14 papers
receiving
991 citations
Hit Papers
What are hit papers?
Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Vaccination greatly reduces disease, disability, death and inequity worldwide
2008854 citationsAndré Fe, Robert Booy et al.Bulletin of the World Health Organizationprofile →
Author Peers
Peers are selected by citation overlap in the author's most active subfields.
citations ·
hero ref
This map shows the geographic impact of André Fe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by André Fe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites André Fe more than expected).
This network shows the impact of papers produced by André Fe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by André Fe. The network helps show where André Fe may publish in the future.
Co-authorship network of co-authors of André Fe
This figure shows the co-authorship network connecting the top 25 collaborators of André Fe.
A scholar is included among the top collaborators of André Fe based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with André Fe. André Fe is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Fe, André, Robert Booy, H.L. Bock, et al.. (2008). Vaccination greatly reduces disease, disability, death and inequity worldwide. Bulletin of the World Health Organization. 86(2). 140–146.854 indexed citations breakdown →
3.
Fe, André. (2002). How the research-based industry approaches vaccine development and establishes priorities.. PubMed. 110. 25–9.33 indexed citations
4.
Chang, Mei‐Hwei, et al.. (1996). Immunogenicity of an inactivated hepatitis A vaccine in healthy children: two years' follow-up.. PubMed. 36(5). 331–5.2 indexed citations
5.
Safary, Assad & André Fe. (1989). Clinical experience with a yeast-derived hepatitis B vaccine.. PubMed. 1(4 Suppl). 1096–8.32 indexed citations
6.
Fe, André. (1988). Clinical experience with a recombinant DNA hepatitis B vaccine.. PubMed. 19(3). 501–10.11 indexed citations
7.
Prinsen, Hetty, Christian Goilav, Assad Safary, André Fe, & P Piot. (1987). Immunogenicity and tolerance of a yeast-derived hepatitis B vaccine in homosexual men.. PubMed. 63 Suppl 2. 147–9.4 indexed citations
8.
Zoppi, G, et al.. (1986). Response to RIT 4237 oral rotavirus vaccine in breast-fed and formula-fed infants.. PubMed. 41(3). 203–8.14 indexed citations
9.
Fe, André. (1985). Worldwide experience with the Oka-strain live varicella vaccine.. PubMed. 61 Suppl 4. 113–20.23 indexed citations
10.
Fe, André, et al.. (1984). Field trial of a heat-stable measles vaccine in Papua New Guinea.. PubMed. 87(6). 249–55.4 indexed citations
11.
Fe, André. (1984). Summary of clinical studies with the Oka live varicella vaccine produced by Smith Kline-RIT.. PubMed. 27(2-3). 89–98.12 indexed citations
12.
Fe, André, et al.. (1980). Protective efficacy of a bivalent (A + C) meningococcal vaccine during a cerebrospinal meningitis epidemic in Rwanda.. PubMed. 60(3). 297–306.25 indexed citations
13.
Fe, André. (1979). Poliomyelitis vaccines in Belgium: 20 years of experience.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 43. 187–93.4 indexed citations
14.
Hrabar, Adrian D., et al.. (1978). A placebo-controlled dose-response study of the reactogenicity and immunogenicity of a cold-adapted recombinant A/Victoria/3/75 (H3N2) live influenza virus candidate vaccine in healthy volunteers.. PubMed. 39. 53–60.28 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.